Literature DB >> 11673565

Donor IFN-gamma receptors are critical for acute CD4(+) T cell-mediated cardiac allograft rejection.

A C Wiseman1, B A Pietra, B P Kelly, G R Rayat, M Rizeq, R G Gill.   

Abstract

Recent studies using mouse models demonstrate that CD4(+) T cells are sufficient to mediate acute cardiac allograft rejection in the absence of CD8(+) T cells and B cells. However, the mechanistic basis of CD4-mediated rejection is unclear. One potential mechanism of CD4-mediated rejection is via elaboration of proinflammatory cytokines such as IFN-gamma. To determine whether IFN-gamma is a critical cytokine in CD4-mediated acute cardiac allograft rejection, we studied whether the expression of IFN-gamma receptors on the donor heart was required for CD4-mediated rejection. To investigate this possibility, purified CD4(+) T cells were transferred into immune-deficient mice bearing heterotopic cardiac allografts from IFN-gamma receptor-deficient (GRKO) donors. While CD4(+) T cells triggered acute rejection of wild-type heart allografts, they failed to trigger rejection of GRKO heart allografts. The impairment in CD4-mediated rejection of GRKO hearts appeared to primarily involve the efferent phase of the immune response. This conclusion was based on the findings that GRKO stimulator cells provoked normal CD4 proliferation in vitro and that intentional in vivo challenge of CD4 cells with wild-type donor APC or the adoptive transfer of in vitro primed CD4 T cells failed to provoke acute rejection of GRKO allografts. In contrast, unseparated lymph node cells acutely rejected both GRKO and wild-type hearts with similar time courses, illustrating the existence of both IFN-gamma-dependent and IFN-gamma-independent mechanisms of acute allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673565     DOI: 10.4049/jimmunol.167.9.5457

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.

Authors:  Todd J Grazia; Biagio A Pietra; Zachary A Johnson; Brian P Kelly; Robert J Plenter; Ronald G Gill
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

2.  Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.

Authors:  C M Lin; R J Plenter; M Coulombe; R G Gill
Journal:  Am J Transplant       Date:  2016-07-07       Impact factor: 8.086

3.  Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection.

Authors:  Robert J Plenter; Todd J Grazia; David P Nelson; Martin R Zamora; Ronald G Gill; Biagio A Pietra
Journal:  Cell Immunol       Date:  2014-12-06       Impact factor: 4.868

Review 4.  Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms.

Authors:  Christine M Lin; Ronald G Gill
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

5.  Effect of Inhibition of the JAK2/STAT3 Signaling Pathway on the Th17/IL-17 Axis in Acute Cellular Rejection After Heart Transplantation in Mice.

Authors:  Ming Zhang; Ming Xu; Kaijie Wang; Long Li; Jinping Zhao
Journal:  J Cardiovasc Pharmacol       Date:  2021-04-07       Impact factor: 3.105

6.  Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice.

Authors:  James S Young; Stella H-W Khiew; Jinghui Yang; Augustin Vannier; Dengping Yin; Roger Sciammas; Maria-Luisa Alegre; Anita S Chong
Journal:  Front Immunol       Date:  2017-09-20       Impact factor: 7.561

7.  Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro.

Authors:  Woan Ting Tay; Yi-Hsien Fang; Suet Theng Beh; Yen-Wen Liu; Ling-Wei Hsu; Chia-Jui Yen; Ping-Yen Liu
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.